<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Perli E</submitter><funding>UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children</funding><funding>National Institute of Neurological Disorders and Stroke of the National Institutes of Health</funding><funding>Sapienza Universit&amp;amp;amp;#x00E0; di Roma</funding><funding>Medical Research Council</funding><funding>NINDS NIH HHS</funding><funding>Wellcome Trust</funding><pagination>5108</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6434145</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(1)</volume><pubmed_abstract>Primary mitochondrial dysfunction is an under-appreciated cause of cardiomyopathy, especially when cardiac symptoms are the unique or prevalent manifestation of disease. Here, we report an unusual presentation of mitochondrial cardiomyopathy, with dilated phenotype and pathologic evidence of biventricular fibro-adipose replacement, in a 33-year old woman who underwent cardiac transplant. Whole exome sequencing revealed two novel compound heterozygous variants in the TSFM gene, coding for the mitochondrial translation elongation factor EF-Ts. This protein participates in the elongation step of mitochondrial translation by binding and stabilizing the translation elongation factor Tu (EF-Tu). Bioinformatics analysis predicted a destabilization of the EF-Ts variants complex with EF-Tu, in agre</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Novel compound mutations in the mitochondrial translation elongation factor (TSFM) gene cause severe cardiomyopathy with myocardial fibro-adipose replacement.</pubmed_title><pmcid>PMC6434145</pmcid><funding_grant_id>RP116154C89C41C2</funding_grant_id><funding_grant_id>R01 NS083726</funding_grant_id><funding_grant_id>G0800674</funding_grant_id><funding_grant_id>203105/Z/16/Z</funding_grant_id><pubmed_authors>Giordano C</pubmed_authors><pubmed_authors>Glasgow RIC</pubmed_authors><pubmed_authors>d'Amati G</pubmed_authors><pubmed_authors>Pignataro MG</pubmed_authors><pubmed_authors>Cerbelli B</pubmed_authors><pubmed_authors>Falkous G</pubmed_authors><pubmed_authors>Della Monica PL</pubmed_authors><pubmed_authors>He L</pubmed_authors><pubmed_authors>Carbo M</pubmed_authors><pubmed_authors>Hardy SA</pubmed_authors><pubmed_authors>Bonnen PE</pubmed_authors><pubmed_authors>Taylor RW</pubmed_authors><pubmed_authors>Perli E</pubmed_authors><pubmed_authors>Zacara E</pubmed_authors><pubmed_authors>Pisano A</pubmed_authors><pubmed_authors>Morea V</pubmed_authors><pubmed_authors>Re F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Novel compound mutations in the mitochondrial translation elongation factor (TSFM) gene cause severe cardiomyopathy with myocardial fibro-adipose replacement.</name><description>Primary mitochondrial dysfunction is an under-appreciated cause of cardiomyopathy, especially when cardiac symptoms are the unique or prevalent manifestation of disease. Here, we report an unusual presentation of mitochondrial cardiomyopathy, with dilated phenotype and pathologic evidence of biventricular fibro-adipose replacement, in a 33-year old woman who underwent cardiac transplant. Whole exome sequencing revealed two novel compound heterozygous variants in the TSFM gene, coding for the mitochondrial translation elongation factor EF-Ts. This protein participates in the elongation step of mitochondrial translation by binding and stabilizing the translation elongation factor Tu (EF-Tu). Bioinformatics analysis predicted a destabilization of the EF-Ts variants complex with EF-Tu, in agre</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Mar</publication><modification>2026-05-03T12:09:45.846Z</modification><creation>2019-06-06T21:02:52Z</creation></dates><accession>S-EPMC6434145</accession><cross_references><pubmed>30911037</pubmed><doi>10.1038/s41598-019-41483-9</doi></cross_references></HashMap>